Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2002 2
2004 1
2005 5
2006 1
2008 5
2009 7
2010 2
2011 5
2012 6
2013 2
2014 2
2015 2
2016 1
2017 1
2018 3
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).
Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M. Maher TM, et al. Among authors: abi saab w. BMJ Open Respir Res. 2019 May 21;6(1):e000422. doi: 10.1136/bmjresp-2019-000422. eCollection 2019. BMJ Open Respir Res. 2019. PMID: 31179008 Free PMC article.
GPCR Signaling Mediates Tumor Metastasis via PI3Kβ.
Khalil BD, Hsueh C, Cao Y, Abi Saab WF, Wang Y, Condeelis JS, Bresnick AR, Backer JM. Khalil BD, et al. Among authors: abi saab wf. Cancer Res. 2016 May 15;76(10):2944-53. doi: 10.1158/0008-5472.CAN-15-1675. Epub 2016 Mar 24. Cancer Res. 2016. PMID: 27013201 Free PMC article.
The scopolamine model as a pharmacodynamic marker in early drug development.
Lenz RA, Baker JD, Locke C, Rueter LE, Mohler EG, Wesnes K, Abi-Saab W, Saltarelli MD. Lenz RA, et al. Among authors: abi saab w. Psychopharmacology (Berl). 2012 Mar;220(1):97-107. doi: 10.1007/s00213-011-2456-4. Epub 2011 Sep 8. Psychopharmacology (Berl). 2012. PMID: 21901320 Clinical Trial.
41 results